CAR T:

Amanda V Finck1,2, Ziming Wang1,2, Donna Gonzales1,2

  • 1Department of Pathology and Laboratory Medicine, Center for Cellular Immunotherapies, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104.

概括

通过识别CD19+ B细胞,工程双向CAR T细胞通过识别CD19+ B细胞,在固体瘤中增强了外周扩张和抗瘤活性. 这一策略改善了CAR T细胞治疗对没有淋巴细胞减少的固体瘤的治疗结果.